Jul 23, 2026
Michalis Papadakis, CEO and Co-Founder of Brainomix, is developing AI technology to automate the analysis of brain scans of stroke patients, addressing the critical clinical gap where a majority of patients who should receive treatment are not being identified. The platform identifies stroke location, blocked vessels,...
Jul 23, 2026
Michalis Papadakis, CEO and Co-Founder of Brainomix, is developing AI technology to automate the analysis of brain scans of stroke patients, addressing the critical clinical gap where a majority of patients who should receive treatment are not being identified. The platform identifies stroke location, blocked vessels,...
Jun 30, 2026
Zach Henderson, CEO at MindMaze Therapeutics, has designed a precision neurotherapeutic solution designed to offer a scalable, engaging and immersive platform for patients recovering from strokes or managing Parkinson's disease. The solution is deployed across the entire care continuum from hospital to the...
Jun 30, 2026
Zach Henderson, CEO at MindMaze Therapeutics, has designed a precision neurotherapeutic solution designed to offer a scalable, engaging and immersive platform for patients recovering from strokes or managing Parkinson's disease. The solution is deployed across the entire care continuum from hospital to the...
Jun 30, 2026
Daniele De Mari, Founder and CEO of Neurogram, points out the significant problem of non-standardized data formats in EEG (electroencephalography), compared to the universal standard used in radiology. Neurogram has developed a hardware-agnostic, cloud-based solution that standardizes EEG data from...